Enter your login e-mail to the account
Search
- The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - MALIGNANT LYMPHOMA DIAGNOSIS FROM THE PATHOLOGIST´S POINT OF VIEW
prof. MUDr. Lukáš Plank, CSc.
(2/2008, Review articles ) - The polymorphisms of DNA-repair genes in pathogenesis of NHL
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD., RNDr. Lucia Klimčáková, PhD., prof. RNDr. Ján Šalagovič, CSc.
(6/2013, Review articles ) - Classification and diagnostics of indolent B-cell neoplasms in the context of the new WHO classification 2016
MUDr. Tomáš Balhárek, PhD., prof. MUDr. Lukáš Plank, CSc.
(2/2017, Spectrum ) - Prophylaxis and treatment of lymphomatous central nervous system infiltration
MUDr. Alexander Wild, MUDr. Juliana Holasová
(3/2019, Main topic ) - Mantle cell lymhoma and modern therapy – benefit for the patient
MUDr. Tomáš Guman, PhD., MUDr. Monika Hlebašková
(3/2017, Original articles & case reports ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Lenalidomide in the treatment of mantle cell lymphoma
Doc. MUDr. Ľuboš Drgoňa, CSc., MHA
(6/2017, Drugs & drug classes ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - Biology of malignant lymphomas
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD.
(2/2014, Main topic ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - Mantle cell lymphoma
MUDr. Miriam Ladická
(4/2017, Spectrum ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Laborathory diagnosis of CLL: cytology, flow cytometry
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD.
(3/2014, Oncohematology Review )